The Great American Smokeout is in November. This is the perfect time to educate people with a smoking history about lung cancer screening options.
Read MoreHealth Awareness:
Promoting Lung Cancer Screenings
If you’re currently using the Lung Cancer HRA in your marketing campaigns mix, now is an excellent time to review CTAs and email follow-ups to make sure they are meeting the needs of the consumer and the health system. Check targeting to verify that those with the proper smoking history are the audience. Do not market to individuals who have quit more than 15 years ago or are under age 55. If the Lung Cancer HRA is not in use for your health system, consider the community benefit of such a tool. This HRA can be up and running on site in as little as a day. Now is the time to lock in pricing and get it ready for those 2020 Resolutions to “Quit Smoking!”
Read MoreHealth Awareness/Observance:
Great American Smokeout 2019 – Drive Lung Cancer Screenings
Leverage the Great American Smokeout, the American Cancer Society’s annual anti-smoking campaign to increase patient visits.
Read MoreMotivate Lung Screenings All Year Long
Our Lung Cancer HRA can motivate lung screenings objectively, based on respected research. The recommendations are tailored to individuals based on personal risk factors and widely accepted guidelines.
Read MoreHealth Awareness:
Breathe Easier with a Lung Cancer HRA
When does your system generally talk to consumers about lung cancer and smoking cessation? It’s a challenging topic. How can you market without offending? Inspire without demotivating?
Read MoreHealth Awareness Month:
HRAs Build Intrinsic Motivation for Lung Screenings All Year Long
Our Lung Cancer HRA can create internal, or intrinsic motivation for lung screenings by objectively quantifying whether or not someone should talk to a doctor about having a lung screening by delivering tailored advice based on personal risk factors and widely accepted guidelines.
Read MoreConnect With At-Risk Patients For Early Lung Cancer Screenings
In February 2015, the Centers for Medicare & Medicaid Services (CMS) issued a final national coverage determination that provides for Medicare coverage of screening for lung cancer with low-dose computed tomography (LDCT). “This is the first time that Medicare has covered lung cancer screening. This is an important new Medicare preventive benefit, since lung cancer […]
Read MoreHealth Risk Assessment (HRA):
Lung Cancer Risk Assessment
Identify your lung cancer risk factors and learn if lung cancer screening is recommended for you.
Read More
